CrushSCI.com
83平均天数
56中位天数
13最短天数
238最长天数
372025发文量

Paper Review Records

全部论文审稿周期

13 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

76 天

Longitudinal changes in pancreatic iron burden in non-transfusion-dependent thalassemia: A multicenter MRI study

作者
Antonella Meloni; Laura Pistoia; Michela Zerbini; Luigi Barbuto; Stefania Renne; Vincenzo Positano; Filomena Longo; Paolo Ricchi; Valerio Cecinati; Elisabetta Corigliano; Giovan Battista Ruffo; Andrea Barison展开收起
作者单位
Bioengineering Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy; Unità Operativa Complessa Ricerca Clinica, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy; Diagnostica per Immagini e Radiologia Interventistica, Ospedale del Delta, Lagosanto, FE, Italy; Unità Operativa Complessa Radiologia Generale e di Pronto Soccorso, Azienda Ospedaliera di Rilievo Nazionale “A. Cardarelli”, Napoli, Italy; Struttura Complessa di Cardioradiologia-UTIC, Presidio Ospedaliero “Giovanni Paolo II”, Lamezia Terme, Italy; Unità Operativa Complessa Talassemie ed Emoglobinopatie, Azienda Ospedaliero- Universitaria Arcispedale S. Anna, Ferrara, Italy; Unità Operativa Semplice Dipartimentale Malattie Rare del Globulo Rosso, Azienda Ospedaliera di Rilievo Nazionale “A. Cardarelli”, Napoli, Italy; Struttura Semplice di Microcitemia, Ospedale “SS. Annunziata” ASL Taranto, Taranto, Italy; Ematologia Microcitemia, Ospedale San Giovanni di Dio – ASP Crotone, Crotone, Italy; Unità Operativa Complessa Ematologia con Talassemia, ARNAS Civico “Benfratelli-Di Cristina”, Palermo, Italy; Cardiology and Cardiovascular Medicine, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy展开收起
PDF源文件 DOI 网页
117 天

A trispecific triabody targeting A, B, and Rh(D) antigens for antigen blocking to expand red blood cell transfusion compatibility: An in vitro assessment

作者
Saleha Hafeez; Muhammad Faraz Bhatti; Muhammad Asghar展开收起
作者单位
Department of Biomedicine, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology (NUST), Sector H-12, Islamabad, 44000, Pakistan; Department of Agricultural Sciences and Technology, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology (NUST), Sector H-12, Islamabad, 44000, Pakistan; Department of Biomedical Engineering, School of Mechanical and Manufacturing Engineering, National University of Sciences and Technology, Sector H-12, Islamabad, 44000, Pakistan; Department of Biology, Lund University, Lund, Sweden; Department of Protein Science, KTH Royal Institute of Technology, Sweden; Department of Sports Sciences and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark展开收起
PDF源文件 DOI 网页
238 天

Real-world experience in management of patients with PNH treated with iptacopan: A case series

作者
Mark Orland; Srinivasa Sanikommu; Carmelo Gurnari; David Dingli; Jaroslaw P. Maciejewski展开收起
作者单位
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA; Levine Cancer Institute, Charlotte, NC, USA; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy; Mayo Clinic, Rochester, MN, USA展开收起
PDF源文件 DOI 网页
49 天

Metabolic dysregulation linked to sickling tendency in sickle cell anemia independent of HbF

作者
Sigrid van der Veen; Amira Idrizovic; Tiziana Sanavia; Emmanuel Adu; Slimane Allali; David Beneitez; Pablo Bartolucci; Bart J. Biemond; Maria Paola Boaro; Emmanuelle Bourdelier; Betzabel Cajiao Garcia; Marjon H. Cnossen; Anna Collado Gimbert; Raffaella Colombatti; Mirco D'Agnolo; Piero Fariselli; Karin Fijnvandraat; Nicolas Hebert; Judith J.M. Jans; Aida Kidane; Caroline Le Van Kim; Mickael Marin; Elisabetta Mezzalira; Mariane De Montalembert; Erfan Nur; Sara Reidel; Anita W. Rijneveld; Anna Ruiz-Llobet; Cesare Rollo; Saskia E.M. Schols; Marissa J.M. Traets; Nanda M. Verhoeven-Duif; Richard van Wijk; Minke A.E. Rab; María del Mar Mañú-Pereira; Eduard J. Van Beers展开收起
作者单位
Center for Benign Hematology, Thrombosis and Hemostasis - Van Creveldkliniek, University Medical Center Utrecht, Utrecht, the Netherlands; Section Metabolic Diagnostics, Department of Genetics, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands; Rare Anemia Disorders Laboratory, Childhood Cancer and Blood Disorders Group, Vall d'Hebron Institut de Recerca, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; AI and Computational Biomedicine Unit, Department of Medical Sciences, University of Torino, Torino, Italy; IMRB, INSERM U955, Paris Est Créteil University UPEC, Créteil, France; Sickle Cell Referral Center, UMGGR, Plateforme D'Expertise Maladies Rares Grand Paris Est, UPEC Hôpitaux Universitaires Henri Mondor, APHP, Créteil, France; Université Paris Cité, INSERM, EFS, BIGR U1134, RedXPERT Platform, 75015, Paris, France; Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center, Necker-Enfants malades Hospital, AP-HP, Université Paris Cité, Paris, France; Hematology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institute of Oncology, Barcelona, Spain; Réseau Erythrocyte Drépanocytose, RED, Créteil, France; Department of Hematology, Amsterdam University Medical Center, University of Amsterdam, the Netherlands; Department of Women's and Children's Health, University of Padua, Padova, Italy; Initiatives IdEx Globule Rouge d'Excellence (InIdex GR-Ex), Université Paris Cité, Paris, France; Department of Pediatric Hematology and Oncology, Erasmus MC Sophia Children's Hospital, Erasmus University Medical Center, Rotterdam, the Netherlands; Pediatric Oncology and Hematology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Department of Pediatric Hematology, Amsterdam UMC, Emma Children's Hospital, Amsterdam, the Netherlands; Sanquin Research and Landsteiner Laboratory, Amsterdam, the Netherlands; Universitat Politècnica de Catalunya - BarcelonaTech (UPC), Barcelona, Spain; Department of Hematology, Erasmus University Medical Center Rotterdam, the Netherlands; Pediatric Hematology, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands; Red Blood Cell Research Group, Central Diagnostic Laboratory, University Medical Center Utrecht, Utrecht, the Netherlands展开收起
PDF源文件 DOI 网页
30 天

Recurrent KCNN4 p.Ser314Pro variant in a child with Gardos channelopathy: a 6-year follow-up

作者
Manuel Vargas-Pabón; Lorena García-Iglesias; Olga Castro-González; Marco Hernández-Martín展开收起
作者单位
Department of Hematology and Hemotherapy, Hospital de Jarrio, Asturias, Spain; Department of Hematology and Hemotherapy, Hospital San Agustín, Avilés, Asturias, Spain展开收起
PDF源文件 DOI 网页
81 天

Living with sickle cell disease in the Arab world: Quality of life beyond clinical severity

作者
May AlMoshary; Ahmad Ali Alharbi; Ekremah A. Alzarea; Alia Alfaraedi; Shaimaa M. Hassan; Lamia Abdelbary Gad; Ezeldine K. Abdalhabib; Mohammad Saeed Aldosari; Mohamed Hanafy Morsy展开收起
作者单位
Department of Basic Science, College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia; Department of Basic Medical Sciences, College of Medicine, Majmaah University, Majmaah, 11952, Saudi Arabia; Hematopathology, Department of Pathology, College of Medicine, Jouf University, Sakaka, Saudi Arabia; Department of Pathology and Laboratory Medicine, P.O. Box 2925 (32), Riyadh, 11461, King Saud University Medical City, Saudi Arabia; Histology and Cell Biology Department, Faculty of Medicine, Menoufia University, Shebin El Koum, Egypt; Department of Histology, General Medicine Practice Program, Batterjee Medical College, Aseer, 61961, Saudi Arabia; Department of clinical pathology, Faculty of Medicine for girls, Al Azhar University, Egypt; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences-AlQurayyat, Jouf University, Saudi Arabia; Makkah Healthcare Cluster, KAAH, Saudi Arabia; Department of Clinical Pathology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt; King Abdulaziz Hospital, MHC, Makkah Al-Mokarrama, Saudi Arabia展开收起
PDF源文件 DOI 网页

FAQ

BLOOD CELLS MOLECULES AND DISEASES审稿要多久?

截至2026-11-19,CrushSCI 收录了 BLOOD CELLS MOLECULES AND DISEASES 的 13 篇完整审稿记录。最快一篇从收稿到录用用了 13 天(Should we longitudinally monitor blood viscosity in patients with sickle cell anemia?,2026-04-22 收稿,2026-05-05 录用),最慢一篇用了 238 天;平均 83 天,中位数 56 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。